Louise F. Momparler

Pilot phase l-ll study on 5-aza-2??-deoxycytidine (Decitabine) in patients with metastatic lung cancer

Richard L. Momparler, David Y. Bouffard, Louise F. Momparler et al. · Anti-Cancer Drugs · 1997 · 212 citations

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

Georges E. Rivard, Richard L. Momparler, Jocelyn Demers et al. · Leukemia Research · 1981 · 180 citations

Hematological Malignancy, Oncology, Medicine +5

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

Sepideh Shaker, Mark L. Bernstein, Louise F. Momparler et al. · Leukemia Research · 2003 · 103 citations

Hematological Malignancy, Medicinal Chemistry, Oncology +11

Enhancement of antineoplastic action of 5-aza-2???-deoxycytidine by zebularine on L1210 leukemia

Maryse Lemaire, Louise F. Momparler, Mark L. Bernstein et al. · Anti-Cancer Drugs · 2005 · 94 citations

Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β-d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia

Richard L. Momparler, Louise F. Momparler, Johanne Samson · Leukemia Research · 1984 · 86 citations

Hematological Malignancy, Medicinal Chemistry, Oncology +10